VTN and cancer: Vitronectin is a component of the ECM that is involved in cancer cell adhesion and migration through interaction of its receptor integrin alphavbeta5 or alphavbeta3 [51,52], urokinase-type plasminogen activator receptor (uPAR) complex [53] and PAI-1 [54].